The successful translation of nanoparticle-based therapies from the laboratory to the clinic requires a thorough understanding of their behavior and interaction with biological systems. Athna Biotech specializes in providing customized bioanalytical services to support the development and optimization of nanoparticle-based therapies. Our team of experienced scientists offers a comprehensive suite of bioanalytical techniques to evaluate nanoparticle properties. We use state-of-the-art equipment and techniques to provide our clients with high-quality data and analysis to help them make informed decisions about their nanoparticle-based therapies.

 Our Technical Data include: 

• Cell-based assays - custom development and validation of assays to evaluate cellular responses to nanoparticles.
• Biomarker Analysis - Quantification of specific biomarkers in biological samples using techniques such as ELISA, Western blotting, or mass spectrometry.
• Pharmacokinetic and pharmacodynamic analysis - evaluation of the absorption, distribution, metabolism and excretion of nanoparticles in biological systems.
• Toxicology studies - in vitro and in vivo toxicity testing to evaluate the safety and efficacy of nanoparticles.
• In vitro and in vivo imaging - evaluation of nanoparticle distribution and localization using techniques such as confocal microscopy, fluorescence imaging, or positron emission tomography (PET).
• Formulation Analysis - Characterization of the physical and chemical properties of nanoparticle formulations to optimize drug delivery and efficacy.